Agreement - November 4, 2026
Nightingale signs two brain health proteomics deals
Finnish Nightingale Health has signed two proteomics service agreements worth USD 1 million each, one with Alzheimer’s Research UK and one with medical research organization LifeArc. Both cover analysis of UK Biobank samples for research into neurodegenerative diseases.
Business Award - October 30, 2026
Evaxion wins International Prix Galien Award
Copenhagen-based Evaxion has won the 2026 International Prix Galien Award for best digital health solution for its AI-Immunology platform. It is the first time a Danish company has received the prestigious award.
MedTech Business - October 29, 2026
Glycorex moves into universal blood products
Glycorex Transplantation is broadening its strategy to develop standardized, universal blood products for civilian healthcare, emergency preparedness, and military medicine. The work will be carried out through its new subsidiary, Glycorex Universal Blood Products (UBP).
MedTech Business - October 28, 2026
Gradientech adds last-resort antibiotic to rapid resistance test
Uppsala-based diagnostics company Gradientech has launched QuickMIC GN02, a new panel for its rapid antibiotic susceptibility testing (AST) system that gives results for hard-to-treat Gram-negative bacteria in 3 hours and 14 minutes. The panel is CE marked under the EU's IVDR.
Acquisition - October 26, 2026
Episurf moves to sell medtech business
Episurf Medical has signed a letter of intent with Canada’s Oligo Medic for the possible sale of its medical technology business, as the Swedish company shifts its focus to real estate.
MedTech Business - October 22, 2026
Getinge lifts margin in third quarter
Swedish medtech company Getinge raised its adjusted EBITA margin to 15.1% in the third quarter of 2026, from 13.1% a year earlier, while organic sales grew 2.1%. The company kept its forecast of 3–5% organic sales growth for the full year.